Mylan's Competitors, Revenue, Number of Employees, Funding and Acquisitions

Mylan engages in the development, manufacture and distribution of generic medical products.

Mylan's headquarters is locat...
Read more

Based on data from Mylan's latest SEC filings

Annual Revenue

Based on data from Mylan's latest SEC filings

Employees

Heather Bresch's photo - CEO of Mylan

CEO

Heather Bresch

CEO Approval Rating

85/100

OVERVIEW

Founded:

1961

Headquarters:

CanonsburgPennsylvania

Status:

PublicIndependent Company of NASDAQMYL

Industry Sector:

Pharmaceuticals

SIC Code:

Top Competitors or Alternatives

Missing a competitor? Contribute!

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Cipla a competitor of Mylan?

Want more news like this in your inbox? Get access for free

Competitive Analysis

TOP COMPETITORS OR ALTERNATIVES

TEVA Pharmaceuticals is the biggest rival of Mylan. TEVA Pharmaceuticals was founded in 1901, and its headquarters is in Petach Tikva, Center District. TEVA Pharmaceuticals operates in the Pharmaceuticals industry. TEVA Pharmaceuticals has 7,535 more employees than Mylan.

Sandoz has been one of Mylan's top competitors. Sandoz is a Private company that was founded in Holzkirchen, Bavaria in 1886. Sandoz is in the Pharmaceuticals industry. Sandoz has 8,500 fewer employees vs. Mylan.

Sanofi is Mylan's #3 rival. Sanofi was founded in 1994 in Paris, Île-de-France. Sanofi is in the Healthcare products field. Sanofi generates $30.5B more revenue than Mylan.

RANK

COMPANY

LEADERSHIP

CEO SCORE

EMPLOYEES

TOTAL FUNDING

REVENUE

Heather Bresch

CEO

- -
35,000
$7.9B
$11.3B
1

Kaare Schultz

President & CEO

75/100
42,535
$5.5B
$17.7B
2

Richard Saynor

CEO

83/100
26,500
- -
$9.9B
3

Paul Hudson

CEO

83/100
106,859
- -
$41.8B
4

Albert Bourla

CEO

60/100
92,400
- -
$53.7B
5

Erez Israeli

CEO

83/100
22,175
- -
$2.2B
6

Umang Vohra

CEO

70/100
12,235
- -
$1.9B
7

Severin Schwan

CEO

54/100
94,052
- -
$932.5M
8

Pascal Soriot

CEO

72/100
59,700
- -
$21.9B
9

Vasant Narasimhan

CEO

81/100
118,393
- -
$50.3B
10

Dilip S. Shanghvi

Managing Director

76/100
30,000
- -
$4.5B

Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$11.3B

Mylan's revenue is the ranked 6th among it's top 10 competitors. The top 10 competitors average 19.7B. Over the last four quarters, Mylan's revenue has grown by 0.9%. Specifically, in Q2 2019's revenue was $2.9B; in Q1 2019, it was $2.5B; in Q4 2018, it was $3.1B; in Q3 2018, Mylan's revenue was $2.8B.

Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Cold-EEZE

Jan 2017

Source »
$50M
Cold-EEZE develops and manufactures zinc gluconate products for cold and throat problems.
Meda AB

Feb 2016

Source »
$7.2B
Meda is a developer and marketer of respiratory, dermatology, pain and inflammation therapy products.

-

-

Dec 2011

Source »
undisclosed
-

These are all the companies that Mylan has acquired. Mylan has acquired 3 companies and its latest acquisition was Cold-EEZE in Jan 2017. Cold-EEZE develops and manufactures zinc gluconate products for cold and throat problems.

Mylan Funding History

Since Mylan was founded in 1961, it has participated in 8 rounds of funding. In total Mylan has raised $7.9B. Mylan's last funding round was on Feb 2012 for a total of $300.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt
Feb 2012
$300M
-
Debt
Nov 2011
$2.5B
-
Private Placement
Nov 2010
$800M
-
Private Placement
Aug 2010
$300M
-
Debt
Oct 2008
$500M
-

Total Funding: $7.9B

Since Mylan was founded in 1961, it has participated in 8 rounds of funding. In total Mylan has raised $7.9B. Mylan's last funding round was on Feb 2012 for a total of $300.0M

Investments

No recent investments found related to Mylan

Mylan News

October 3, 2019The Pharma Letter

First insulin glargine biosimilar, Semglee, launched in Australia

Leading Indian biotech Biocon and Netherlands-incorporated Mylan today announced the launch of Semgle... See more »
September 30, 2019Medical Buyer

Mylan Finalizes Previously Disclosed Settlement With U.S. Securities And Exchange Commission

Mylan N.V. announced that it has finalized a previously disclosed civil settlement with the U.S. Secu... See more »
September 30, 2019Medical Buyer

Mylan To Infuse USD 1 Billion On CapEx In India

Hyderabad: Multinational drug company Mylan has said it will invest USD one billion in the next 5-6 y... See more »
September 29, 2019The Chronicle Herald

Mylan to pay $30 million U.S. SEC fine related to EpiPen overcharge probe | The Chronicle Herald

By Jonathan Stempel (Reuters) - Mylan NV has agreed to pay a $30 million fine to settle U.S. Securiti... See more »
September 27, 2019The Seattle Times - Business & Tech

Mylan agrees to pay $30M in SEC EpiPen settlement

PITTSBURGH (AP) - Mylan has agreed to pay $30 million in a settlement tied to its failure to tell inv... See more »
September 27, 2019Reuters

Mylan to pay $30 million U.S. SEC fine related to EpiPen overcharge probe

Mylan NV has agreed to pay a $30 million fine to settle U.S. Securities and Exchange Commission charg... See more »
September 27, 2019Seeking Alpha

Mylan down on rumored SEC lawsuit

Mylan Press Releases

February 28, 2019PR Newswire

Mylan to Present at Raymond James 40th Annual Institutional Investors Conference

HERTFORDSHIRE, England and PITTSBURGH, Feb. 28, 2019 /PRNewswire/ -- Global pharmaceutical company My... See more »
November 26, 2018PR Newswire

Mylan to Present at Nasdaq's 39th London Investor Conference

HERTFORDSHIRE, England and PITTSBURGH, Nov. 26, 2018 /PRNewswire/ -- Global pharmaceutical company My... See more »
November 5, 2018StreetInsider

Mylan Reports Third Quarter 2018 Results and Reaffirms 2018 Guidance

Mylan N.V. (NASDAQ: MYL) today announced its financial results for the quarter and nine months ended ... See more »
October 18, 2018PR Newswire

Mylan Adds to Women's Healthcare Portfolio With Launch of Generic Depo-Provera® Injection

HERTFORDSHIRE, England and PITTSBURGH, Oct. 18, 2018 /PRNewswire/ -- Global pharmaceutical company My... See more »
September 17, 2018PR Newswire

Theravance Biopharma and Mylan Report New Data from Phase 3 Studies of YUPELRI (revefenacin) in Oral Presentation at the European Respiratory Society International Congress

DUBLIN and HERTFORDSHIRE, England and PITTSBURGH, Sept. 17, 2018 /PRNewswire/ -- Theravance Biopharma... See more »
August 7, 2018streetinsider

Mylan Reports Second Quarter 2018 Results and Updates 2018 Guidance

HERTFORDSHIRE, England and PITTSBURGH, Aug. 8, 2018 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today an... See more »
July 20, 2018PR Newswire

Mylan Again Defeats Allergan's Efforts to Deny Patients Access to More Affordable Medicine

HERTFORDSHIRE, England and PITTSBURGH, July 20, 2018 /PRNewswire/ -- Global pharmaceutical company My... See more »

Mylan Videos

September 10, 2018Mylan Youtube Channel

"Better Health for a Better World" on YOUTUBE

May 26, 2017Mylan Youtube Channel

"Life at Mylan: Shazia" on YOUTUBE

February 16, 2017Mylan Youtube Channel

"You Have a Champion in Mylan" on YOUTUBE

October 25, 2016Mylan Youtube Channel

"Matyas's Career" on YOUTUBE

May 4, 2016Mylan Youtube Channel

"The Mylan Story" on YOUTUBE

Social Statistics

Headquarters

1000 Mylan Blvd

Canonsburg, Pennsylvania15317

724-514-1800

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Mylan engages in the development, manufacture and distribution of generic medical products. Mylan was founded in 1961. Mylan's headquarters is located in Canonsburg, Pennsylvania, USA 15317. It has raised 7.9B in 8 rounds. The latest round was in Feb ...

CEO

Mylan's CEO, Heather Bresch, currently has an approval rating of 85%. Mylan's primary competitors are TEVA Pharmaceuticals, Sandoz & Sanofi.

Website

mylan.com

Frequently Asked Questions about Mylan

  1. When was Mylan founded?

    Mylan was founded in 1961
  2. Who is Mylan's CEO?

    Mylan's CEO is Heather Bresch
  3. How much revenue does Mylan generate?

    Mylan generates $11.3B in revenue
  4. How much funding does Mylan have?

    Mylan has historically raised $7.9B in funding
  1. Where is Mylan's headquarters?

    Mylan's headquarters is in Canonsburg Pennsylvania, USA
  2. How many employees does Mylan have?

    Mylan has 35,000 employees
  3. What sector does Mylan operate in?

    Mylan is in Pharmaceuticals
  4. Who are Mylan's competitors?

    Mylan's top competitors are TEVA Pharmaceuticals, Sandoz, Sanofi